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3NASA Human Research Program
• Program goals
– Perform research necessary to understand and reduce spaceflight human health and 
performance risks in support of exploration
– Enable development of human spaceflight medical and human performance standards
– Develop and validate technologies that serve to characterize and reduce medical risks 
associated with human spaceflight
Seat layout for contingency EVA Example of a study on the effects of center 
of gravity on performance
Clay Anderson centrifuges Nutrition 
blood samples during Increment 15
An Applied Research Program
Destination ‐ MARS
4
Integrated Path to Risk Reduction
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HRP Integrated Science Plan
• Risks amenable to translational approach
– Immune
– Cancer
– Bone (Osteo/Fracture)
– Oxidative Stress & Damage
– VIIP
– Nutrition
– Artificial Gravity
 To effectively use microgravity and other 
characteristics of the space environment to enhance 
our understanding of fundamental biological 
processes
 To develop the scientific and technological 
foundations for a safe, productive human presence in 
space for extended periods and in preparation for 
exploration
 To apply this knowledge and technology to improve 
our nation's competitiveness, education, and the 
quality of life on Earth 
SPACE BIOLOGY PROGRAM GOALS
• Elevate the priority of research in the agenda for space 
exploration
• Select research likely to provide value to an optimal range 
of future mission designs
• Develop a comprehensive database that is accessible to 
the scientific community
• Implement a translational science component to ensure 
bidirectional interactions between basic science and the 
development of new mission options
• Encourage and accommodate team science approaches to 
what are inherently complex multidisciplinary challenges
Decadal Survey Recommendations
Source: Life and Physical Sciences Research for a New Era of Space Exploration: An Interim Report, National Research Council, 2010
 Harness biology in reliable, robust, engineered 
systems to support NASA’s exploration and science 
missions, to improve life on Earth, and to help shape 
NASA’s future.
SYNTHETIC BIOLOGY PROGRAM 
GOALS
 To study the origins, evolution, distribution, and future 
of life in the universe.
 To answer: 
 How does life begin and evolve?
 Is there life elsewhere in the Universe?
 What is the future of life on Earth and beyond? 
Astrobiology Institute Goals
Source: Life and Physical Sciences Research for a New Era of Space Exploration: An Interim Report, National Research Council, 2010
Translational Research: Key Component of an Active Research 
Program
HUMAN RESEARCH PROGRAM AND SPACE BIOLOGY INTERSECTIONS
Space Biology         Synergism     Human Research Program
Study how life 
responds, adapts,  
develops, interacts 
and evolves in the 
space environment 
and across the 
gravitational 
spectrum
• Cell, Microbial and 
Molecular Biology
• Organismal & 
Comparative Biology
• Developmental 
Biology
Translational 
Research 
• SB provides knowledge 
to help HRP identify 
risks and develop 
countermeasures
• HRP advises SB in 
defining research goals 
and priorities
• Common areas:
o Animal research
o Cells & Tissues 
Research
o Immunology
o Wound healing & 
fracture repair
o Bone and muscle
o Radiation/micro-g 
interactions
o Oxidative Stress and 
Damage (OSaD)
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Science exploring 
the unknown
Identify, characterize, 
and  mitigate the risks 
to human health and 
performance in space
•Exercise Countermeasures 
•Physiological 
Countermeasures 
•Space Radiation Biology 
•Behavioral Health and 
Performance
•Space Human Factors and 
Habitability
•Exploration Medical 
Capability
Science addressing 
the known risks
 Translational Science at NASA
 Synergy between Space Biology and HRP**
 Basic Research helps close HRP Gaps and Risks** 
 Examples of Translational Research at NASA**
 Synergies with Synthetic and Astrobiology (Ex: OSaD and there 
are others)
 Synergies with other programs (Gov./ Commercial/ Academic) 
 Potential Products & Strategies**
 Analogs
 Standard Model Organisms
 Teams
Synergistic Avenues Being Considered
** Indicates Already In Progress
ANALYSIS OF HRP-SB OVERLAP
Goodness of Fit: HRP and SB
Good
13%
Partial
18%None
69%
HRP Risk ShortTitle #Gaps Relevant Gaps (TG)
Aerobic 4 4
Arrhythmia 4 1 3
ARS 8 1 3 5
Bmed 8 1 7
Cancer 15 5 6 4
CNS 8 3 5
Degen 8 1 4 3
Dust 6 6
EVA 8 0 2 6
ExMC 32 0 4 28
Food 4 4
Fracture 11 3 2 6
Hab 6 6
HARI 4 4
HCI 7 1 6
Immune 10 7 2 1
IVD 1 1
Microhost 4 3 1
Muscle 13 1 2 10
(J. Smith, T. Goodwin
.
.
.
Total good+partial
31%
78 Gaps
Most Overlap
Immune
Cancer
CNS
Osteo/Fracture
Highest Priorities by 
HRP
***
Good
Partial
None
Translational Activities
 Integrated HERO solicitation
 HRP annual major release plus periodic appendices
 To include Space Biology in overview
 AG synergy
 New HRP research portfolio
 Includes animal and cell components
 Grants with animal/human transition
 Omics
 Integrated/personalized countermeasures
 CASIS interaction
IMMUNE RISK EXEMPLAR 
HRP Gap Title SpaceBioGuiding Question
IM1: Does spaceflight alter immune function?
IM5: What is the time course and 
etiology of immune changes?
OCB‐4: Are the normal defense systems of organisms 
compromised at fractional or hyper- gravity, e.g. 
mammalian immune system, wound healing, 
including fracture repair?IM3: Are there suitable analogs for immune 
dysregulation?
IM4: Can in‐flight hardware to evaluate 
hematology/infection/immunity be developed?
OCB‐4
CMM‐4: Does the enhanced virulence observed with 
Salmonella typhimurium cultures flown in space occur in other 
species?
IM6: What are the cumulative effects of 
chronic immune dysfunction on missions 
greater than six months?
OCB‐4
DEV‐3: Do organisms that are raised in altered gravity 
environments develop normally, i.e., structurally, 
physiologically, behaviorally?  Are reproduction, lifespan and 
the aging processes affected? Are changes expressed in altered 
g environment reversible when returned to 1g?
(J. Smith, T. Goodwin)
BONE--OSTEO / FRACTURE RISKS EXEMPLAR
HRP Gap Title SpaceBioGuiding Question
Bone 1: a) Is there an increased lifetime risk of 
fragility fractures/osteoporosis in astronauts; b) is 
bone strength completely recovered post-flight, 
and does BMD reflect it; c) what are the risk 
factors for poor recovery of BMD/bone strength?
OCB‐4: Are the normal defense systems of organisms 
compromised at fractional or hyper- gravity, e.g. 
mammalian immune system, wound healing, 
including fracture repair?
DEV-3: Do organisms that are raised in altered gravity 
environments develop normally, i.e., structurally, 
physiologically, behaviorally?  Are reproduction, 
lifespan and the aging processes affected? Are 
changes expressed in altered g environment 
reversible when returned to 1g?
Bone 10: How can skeletal adaptation be 
monitored during flight to a) reflect changes in 
bone turnover/calcium kinetics, b) to determine 
whether there is a plateau in bone loss and c) to 
evaluate gender effects?
OCB‐2: How do changes in gravity affect the 
regulatory mechanisms that govern alterations in the 
musculoskeletal system in animals and lignin 
formation in plants?Osteo 7: We need to identify options for mitigating 
early onset osteoporosis before, during and after 
spaceflight.
(J. Smith, T. Goodwin)
NASA TRANSLATIONAL RESEARCH EXEMPLAR: BONE 
PHYSIOLOGY
Effects on Cells and/or Animals
- Loss of bone density 
- Impaired bone healing
- Cell and molecular mechanisms of bone loss emerging 
- Drug countermeasures to flight bone loss in mice appear effective 
Implications for Astronaut Health
- Increased risk of fracture
- An anti-bone resorption drug and a pro-bone forming treatment tested in flight mice minimized bone 
loss also tested in humans
- Centrifugation in rats prevented negative effects of spaceflight on long-bone mechanical properties
Related Potential Countermeasures in Space
- Weight bearing activity essential to maintain bone density
- Artificial gravity options under study
- Drug treatment (Amgen) for lessening bone resorption and promoting formation received FDA 
approval in 2010 for treatment of osteoporosis.  
- A 2nd drug developed, FDA approval anticipated 2017 
Earth Benefits
- More comprehensive understanding of bone formation, growth, maintenance, healing
- Optimize treatment of osteoporosis and disuse arthritis in women and 
men
- Potential adjunct cancer treatments
